Korbecki, J.; Kupnicka, P.; Barczak, K.; Bosiacki, M.; Ziętek, P.; Chlubek, D.; Baranowska-Bosiacka, I.
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers 2023, 15, 4555.
https://doi.org/10.3390/cancers15184555
AMA Style
Korbecki J, Kupnicka P, Barczak K, Bosiacki M, Ziętek P, Chlubek D, Baranowska-Bosiacka I.
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers. 2023; 15(18):4555.
https://doi.org/10.3390/cancers15184555
Chicago/Turabian Style
Korbecki, Jan, Patrycja Kupnicka, Katarzyna Barczak, Mateusz Bosiacki, Paweł Ziętek, Dariusz Chlubek, and Irena Baranowska-Bosiacka.
2023. "The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)" Cancers 15, no. 18: 4555.
https://doi.org/10.3390/cancers15184555
APA Style
Korbecki, J., Kupnicka, P., Barczak, K., Bosiacki, M., Ziętek, P., Chlubek, D., & Baranowska-Bosiacka, I.
(2023). The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers, 15(18), 4555.
https://doi.org/10.3390/cancers15184555
